ZUKANORM 50MG TAB 10 S

About

Zukanorm 50mg is an oral antidiabetic medication primarily containing Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, used for the management of type 2 diabetes mellitus. Vildagliptin works by selectively inhibiting the DPP-4 enzyme, which is responsible for the rapid degradation of incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By preserving the active forms of these incretins, Vildagliptin enhances the body's natural ability to control blood glucose levels. This leads to increased glucose-dependent insulin secretion from pancreatic beta cells and reduced glucagon secretion from pancreatic alpha cells. The net effect is a significant reduction in both fasting and postprandial plasma glucose concentrations. Zukanorm 50mg is typically prescribed as an adjunct to diet and exercise, either as monotherapy or in combination with other antidiabetic agents, when glycemic control is not adequately achieved.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control in adults.
• Used as an adjunct to diet and exercise.
• As monotherapy or in combination therapy.

Directions For Use

Take this medication orally as directed by your physician, usually once or twice daily, with or without food.

Benefits

• Effectively lowers blood glucose levels.
• Enhances natural insulin secretion.
• Reduces glucagon levels.
• Low risk of hypoglycemia when used alone.
• Generally well-tolerated.
• Can be used in various combination therapies.

Side Effects

• Headache
• Dizziness
• Nasopharyngitis
• Upper respiratory tract infection
• Cough
• Constipation
• Diarrhea
• Nausea
• Peripheral edema
• Arthralgia
• Pancreatitis (rare)
• Skin reactions

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided as it may affect blood sugar levels.
• Pregnancy - Consult your doctor. This medication is generally not recommended during pregnancy unless clearly necessary, as its safety has not been fully established.
• Breastfeeding - Consult your doctor. It is unknown if Vildagliptin passes into breast milk, and its use during breastfeeding should be carefully considered.
• Liver - Use with caution in patients with liver impairment. Liver function tests should be monitored before and during treatment.
• Kidney - Use with caution and dose adjustment in patients with kidney impairment. Your doctor will determine the appropriate dosage.
• Lung - No specific contraindications, but general health should be considered.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.